Name: Global Herpes Market – Industry Trends and Forecast to 2028
SKU: Healthcare
Price: 4800.00 USD
Availability: InStock
Rating: 4.5 (51 reviews)

Global Herpes Market, By Virus Type (Herpes Simplex and Herpes Zoster), Product (Acyclovir, Docosanol, Valacyclovir, Famciclovir and Others), Drug Type (Prescription Drug and Over-the-counter Drug), Age (Adult and Pediatrics), Route Of Administration (Topical, Oral, and Parenteral), Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, and Others), End Users (Hospitals, Speciality Clinics, and Others) Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Market Analysis and Insights: Global Herpes Market

Global herpes market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyzes that the market is growing with a CAGR of 6.6% in the forecast period of 2021 to 2028 and is expected to reach USD 1,627.74 million by 2028 from USD 1020.91 million in 2020. Rising prevalence of herpes infections and increasing geriatric population are major drivers, which are expected to boost the growth of the market in the forecast period.

A growing number of people are affected with by the herpes simplex virus, which demands highly effective and advanced anti-herpetic treatment to minimize the risk during the treatment. The healthcare systems need highly advanced drugs for numerous different types of herpes during the treatment of patients. Therefore, major market players are highly focusing on product launches and product approvals. Additionally, governments and regulatory bodies are supporting market players by virtue of product approvals.

Rising prevalence of herpes diseases and increase in health expenditure across regions have accelerated the need for anti-herpetic drugs in healthcare facilities, which is driving the growth of the herpes market. In addition, surging volume of geriatric people is further propelling the market growth. However, high cost of anti-herpetic medicines and product recalls are anticipated to hinder market growth in the projected period. On the other hand, strategic initiatives by market players and soaring number of anti-herpetic drugs manufacturers act as an opportunity for this market and is expected to impel the market growth. However, disruption in supply chain of herpes drugs and injections during covid-19 and lack of workforce in pharma industries are key challenges for this market.

The global herpes market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Herpes Market Scope and Market Size

The global herpes market is segmented on the basis of virus type, product, drug type, age, route of administration, distribution channel, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of virus type, the global herpes market is segmented into herpes simplex and herpes zoster. In 2021, herpes simplex segment is expected to dominate the market due to rise in prevalence of herpes infections due to unprotected sex with an infected partner.

On the basis of product, the global herpes market is segmented into acyclovir, docosanol, valacyclovir, famciclovir, and others. In 2021, acyclovir segment is expected to dominate the market as it effectively lessens the infection symptoms and increases healthcare expenditure due to growing healthcare awareness among people.

On the basis of drug type, the global herpes market is segmented into prescription drug and over-the counter drug. In 2021, prescription drug segment is expected to dominate the market owing to rise in prevalence of viral diseases, such as HPV, HIV/AIDS and measles.

On the basis of age, the global herpes market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to growing geriatric population due to the increasing life expectancy of people.

On the basis of route of administration, the global herpes market is segmented into topical, oral, and parenteral. In 2021, topical segment is expected to dominate the market as it is easy to use, non-invasive method with greater patient compliance.

On the basis of distribution channel, the global herpes market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others. In 2021, hospital pharmacies segment is expected to dominate the market owing to evident presence of several major players in the market.

On the basis of end-users, the global herpes market is segmented into hospital, speciality clinics, and others. In 2021, hospitals segment is expected to dominate the market due to growing awareness among people about types of herpes virus and their treatment.

Global Herpes Market Country Level Analysis

The global herpes market is analyzed and market size information is provided based on virus type, product, drug type, age, route of administration, distribution channel, and end users.

Regions covered in the global herpes market report are North America, Europe, Asia-Pacific, South America, and Middle East and Africa. These regions are further segmented into major countries such as the U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia Philippines, and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa.

North America is expected to dominate the global herpes market due to increasing prevalence of herpes in the region and Asia-Pacific is expected to grow with the highest CAGR in the forecast period due to increasing healthcare expenditure in the region. The U.S. is dominating in the market and leading the growth in the global herpes market due to rising herpes infections in the region. The Asia-Pacific region is expected to grow with the most promising growth rate in the forecast period of 2021 to 2028 because of rising prevalence of geriatric population China, Japan, and India. China is dominating the Asia-Pacific market due to rising disposable income in the country. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to technological advancements in the region. Germany is dominating the European market owing to large number of players in the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising healthcare expenditure and high prevalence of herpes infections in the global herpes market are creating new opportunities for players

The route of administration segment in the U.S. is expected to grow with the highest rate and it is dominating the North America region in the forecast period of 2021 to 2028 because of rising prevalence of herpes infections. Germany is leading the market in Europe region and herpes simplex segment is dominating the country due to rising demand for anti- herpetic drugs. In addition, herpes simplex segment is dominating in China, which is leading in the Asia-Pacific region owing to growing geriatric population in the country.

Global herpes market also provides you with detailed market analysis for every country growth in particular industry with the Global herpes market sales, impact of advancement in the Global herpes market and changes in regulatory scenarios with their support for the global herpes market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Global herpes market Share Analysis

Global herpes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to global herpes market.

Major players covered in the report are Abbott, Apotex, Inc., Avet Pharmaceuticals, Inc., Bausch Health Companies, Inc. Cipla, Inc., Dr. Reddy’s Laboratories Ltd., EPI Health, Fresenius Kabi AG, GlaxoSmithKline plc., Glenmark Pharmaceutical Inc., USA, Maruho Co.,Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., RECORDATI S.p.A., Aurobindo Pharma, Amneal Pharmaceuticals LLC, Slavia Pharm S.R.L., and Blistex, Inc., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the growth of the global herpes market.

For instance,

In November 2019, Mylan N.V. announced collaboration with Upjohn, a division of Pfizer, the new company formed would be named Viatris. The merger of both the companies to develop a combined firm has expanded their product portfolio, leading to increased demand for their products in the market.

In September 2018, Avet Pharmaceuticals Inc. announced immediate availability of Acyclovir 200 mg Capsules. This launch enhanced Avet’s broad portfolio of generic oral solid products. This new drug launched by the company has increased its demand in the market, leading to increased revenue in the future.

SKU-53888

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Global Herpes Market – Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Herpes Market

Global Herpes Market Scope and Market Size

Global Herpes Market Country Level Analysis

Competitive Landscape and Global herpes market Share Analysis

Please fill in the below form for Infographics

Research Methodology:

Please fill in the below form for Research Methodology

Customization Available:

Please fill in the below form for Available Customization

Frequently Asked Questions

Browse Related Reports

Browse Related Blogs

Browse Related Press Release

FOLLOW US ON

REPORTS

MARKET INSIGHT

SUPPORT

SOLUTIONS